Related Experiment Video
Updated: Jan 22, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Ferumoxytol-enhanced MRI for surveillance of pediatric cerebral arteriovenous malformations
Yuhao Huang1, Timothy G Singer1, Michael Iv2
11Division of Pediatric Neurosurgery and.
Objective:
Children with intracranial arteriovenous malformations (AVMs) undergo digital DSA for lesion surveillance following their initial diagnosis. However, DSA carries risks of radiation exposure, particularly for the growing pediatric brain and over lifetime. The authors evaluated whether MRI enhanced with a blood pool ferumoxytol (Fe) contrast agent (Fe-MRI) can be used for surveillance of residual or recurrent AVMs.
Methods:
A retrospective cohort was assembled of children with an established AVM diagnosis who underwent surveillance by both DSA and 3-T Fe-MRI from 2014 to 2016. Two neuroradiologists blinded to the DSA results independently assessed Fe-enhanced T1-weighted spoiled gradient recalled acquisition in steady state (Fe-SPGR) scans and, if available, arterial spin labeling (ASL) perfusion scans for residual or recurrent AVMs. Diagnostic confidence was examined using a Likert scale. Sensitivity, specificity, and intermodality reliability were determined using DSA studies as the gold standard. Radiation exposure related to DSA was calculated as total dose area product (TDAP) and effective dose.
Results:
Fifteen patients were included in this study (mean age 10 years, range 3-15 years). The mean time between the first surveillance DSA and Fe-MRI studies was 17 days (SD 47). Intermodality agreement was excellent between Fe-SPGR and DSA (κ = 1.00) but poor between ASL and DSA (κ = 0.53; 95% CI 0.18-0.89). The sensitivity and specificity for detecting residual AVMs using Fe-SPGR were 100% and 100%, and using ASL they were 72% and 100%, respectively. Radiologists reported overall high diagnostic confidence using Fe-SPGR. On average, patients received two surveillance DSA studies over the study period, which on average equated to a TDAP of 117.2 Gy×cm2 (95% CI 77.2-157.4 Gy×cm2) and an effective dose of 7.8 mSv (95% CI 4.4-8.8 mSv).
Conclusions:
Fe-MRI performed similarly to DSA for the surveillance of residual AVMs. Future multicenter studies could further investigate the efficacy of Fe-MRI as a noninvasive alternative to DSA for monitoring AVMs in children.
Insights
Blood pool ferumoxytol-enhanced MRI (Fe-MRI) shows promise for monitoring pediatric arteriovenous malformations (AVMs). This noninvasive imaging technique performed similarly to digital subtraction angiography (DSA) in detecting residual or recurrent AVMs, offering a safer alternative for children.
Area of Science:
- Pediatric Neuroradiology
- Vascular Imaging
- Medical Imaging
Background:
- Children with intracranial arteriovenous malformations (AVMs) require regular surveillance.
- Digital subtraction angiography (DSA) is the current standard but involves significant radiation exposure.
- Minimizing radiation risk in pediatric patients is crucial due to long-term health implications.
Purpose of the Study:
- To evaluate the efficacy of MRI enhanced with a blood pool ferumoxytol (Fe) contrast agent (Fe-MRI) for surveillance of residual or recurrent intracranial AVMs in children.
- To compare the diagnostic performance of Fe-MRI with digital subtraction angiography (DSA).
- To assess the potential of Fe-MRI as a noninvasive alternative to DSA.
Main Methods:
- Retrospective cohort study of pediatric patients with AVMs who underwent both DSA and 3-T Fe-MRI surveillance.
- Independent assessment of Fe-enhanced spoiled gradient recalled acquisition in steady state (Fe-SPGR) and arterial spin labeling (ASL) MRI sequences by blinded neuroradiologists.
- DSA served as the gold standard for comparison; radiation exposure from DSA was quantified.
Main Results:
- Fe-SPGR MRI demonstrated excellent agreement with DSA (κ = 1.00) for AVM surveillance.
- Fe-SPGR MRI achieved 100% sensitivity and 100% specificity in detecting residual AVMs.
- Arterial spin labeling (ASL) showed poorer agreement (κ = 0.53) and lower sensitivity (72%) compared to Fe-SPGR and DSA.
- Fe-MRI provided high diagnostic confidence for radiologists.
Conclusions:
- Fe-MRI, particularly Fe-SPGR sequences, is a highly accurate and reliable tool for surveillance of residual or recurrent intracranial AVMs in children.
- Fe-MRI offers a noninvasive alternative to DSA, significantly reducing radiation exposure for pediatric patients.
- Further multicenter studies are warranted to confirm the efficacy of Fe-MRI in broader clinical practice.
Related Concept Videos
Principles of Disease Surveillance
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Self-Evaluation: Self-Enhancement and Self-Verification
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

